Disclosures. C. Hernandez, MSD: Consultant, Consulting fee and Speaker honorarium; Pfizer: Consultant, Consulting fee and Speaker honorarium. C. Pallares, Pfizer: Consultant, Consulting fee and Speaker honorarium. M. V. Villegas, MSD: Grant Investigator, Grant recipient and Speaker honorarium; Pfizer: Grant Investigator, Grant recipient and Speaker honorarium; Zambon: Grant Investigator, Grant recipient; West: Consultant, Consulting fee and Speaker honorarium; Merck S.A.: Grant Investigator, Grant recipient. Background. Cefazolin is becoming first-line therapy for MSSA infections since it appears to be better tolerated than isoxazolyl penicillins with similar outcomes. An important concern when using cephalosporins as first-line therapy for MSSA is the CzIE, defined as MICs ≥ 16 µg/mL when performed at high bacterial inoculum (~10 7 CFU/mL) compared with standard inoculum (~10 5 CFU/mL). We postulated that release of BlaZ (a lipoprotein) to the extracellular milieu is the mechanism responsible for the CzIE. Confirmation of this phenomenon would permit developing a rapid test to identify this phenomenon in clinical settings.
Extracellular Release of β-Lactamase Is
Methods. We monitored the hydrolysis of 50 μM of nitrocefin by S. aureus supernatants after induction with ampicillin (150 µg/mL) for 1 h. A total of 150 μL of supernatants (after centrifugation) was incubated with 50 μM nitrocefin at 25°C in 20 mM HEPES, pH 7.4, 100 mM NaCl for 30 minutes. Nitrocefin hydrolysis was monitored by following the change in absorbance at 482 resulting from opening of the β-lactam ring of nitrocefin. Visual inspection to monitor color changes was also performed. We initially used 3 strains of MSSA, (i) S. aureus TX0117, a well-characterized strain that exhibits the CzIE; (ii) TX0117c, a derivative of TX0117 that harbors a mutation inactivating BlaZ and abolishing the CzIE, and (iii) ATCC 29213 a BlaZ-positive strain that lacks the CzIE. Subsequently, we validated the methodology in 10 South American isolates of different backgrounds that had been previously characterized for the CZIE.
Results. A statistically significant difference in ODs after 30 minutes was observed in TX0117 (CzIE) vs. TX0117c (no CzIE) and ATCC 29213 (no CzIE) (all P < 0.001), suggesting high BlaZ activity in supernatants of TX0117 and supporting the release of the enzyme as the main mechanism of the CzIE. All South American isolates that exhibited the CzIE were identified by the nitrocefin assay. Of note, isolates producing Type C BlaZ gave a weaker reaction, although still significantly different from isolates without the CzIE. Hydrolysis of nitrocefin was also readily detectable by visual inspection.
Conclusion. and bla NDM-1 was detected in 6 isolates (33.3%). There were 7 (38.8%) colonizations and 11 (61.1%) infections. The significant risk factors for CPK included post-surgery (P = 0.04) and prior antibiotics exposure (P = 0.04). There was a trend toward higher mortality in patients with CPK albeit not significantly (33% vs. 24.5%, P = 0.41).
Conclusion. The automated PCR test has an acceptable accuracy with fair sensitivity for the detection of carbapenemase genes. It is unique that OXA-48 and OXA-48/ NDM-1 are the most common carbapenemases in our institute. This diagnostic test may be use for rapid diagnosis or infection control purposes. Exposure to antibiotics associated with colonization or infection with CPK. Patients with CPK had higher mortality.
Disclosures. All authors: No reported disclosures. Background. The antimicrobial resistance (AMR) crisis represents a serious threat to public health and the healthcare economy. The impact of increasing AMR has resulted in concentrated efforts to increased rapid molecular diagnostics of AMRs. In combination with publicly available web-based AMR databases, whole-genome sequencing (WGS) offers the capacity for detection of antibiotic resistance genes with low turnaround times and is becoming increasingly affordable. Here we sought to examine concordance between WGS-based resistance prediction and phenotypic susceptibility testing results for prospectively collected VRE and MRSA clinical isolates using publicly-available tools.
Whole Genome Sequencing for Antimicrobial Resistance Prediction in
Methods. MRSA and VRE isolates were prospectively collected and underwent WGS at the University of Pittsburgh Medical Center (UPMC) between December 2016 and December 2017. Antibiotic-resistant gene content was assessed by uploading assembled contigs to ResFinder, NCBI betalactamase and CARD using a BLASTn. search. Routine susceptibility was performed by Microscan™. Concordance between genotypic and phenotypic as well as sensitivity, specificity, positive and negative predictive values methods were calculated for each antibiotic/organism combination, using the phenotypic results as the gold standard. In case of discordance between the methods, repeat susceptibility using disc diffusion results was performed and was then considered to be the gold standard method.
Results. Phenotypic susceptibility testing and WGS results were available for 109 and 105 unique MRSA and VRE isolates, respectively. Out of total of 1,058 isolate/antibiotic combinations overall concordance of WGS-web-based prediction with phenotypic susceptibility methods was 99.1% with a sensitivity, specificity, PPV, NPV of 98, 99.6, 99.5, and 98.3%, respectively. Specific concordance for MRSA isolates was 98.8%. with a sensitivity, specificity, PPV and NPV of 97.6, 99.8, 99.7, and 98.5% (Table 1) , while concordance for VRE isolates was 99.3%, with a sensitivity, specificity, PPV and NPV of 98.6, 98.1, 99.1, and 97.2% (Table 2) .
Conclusion. WGS is a reliable predicator of phenotypic resistance for both MRSA and VRE.
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No reported disclosures. October 6, 2018: 12:30 PM Background. The differential identification of carbapenemases relies mostly on molecular techniques. Current phenotypic methods require 18 hours of incubation. We propose a matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS)-based direct-on-target microdroplet growth assay (DOT-MGA) aiming to offer an easy and rapid phenotypic identification of AmpC, KPC, MBL and OXA production.
Accelerated Detection of Carbapenem Resistance Mechanisms in
Methods. Seven well-characterized Enterobacteriaceae strains recommended by EUCAST for carbapenemase detection were analyzed. Synergy between meropenem and carbapenemase inhibitors (phenylboronic acid, aminophenylboronic acid, cloxacillin, dipicolinic acid, ethylenediaminetetraacetic acid, and avibactam) and temocillin resistance were determined using a testing panel developed on a 96-spot MALDI-TOF MS target (MBT Biotarget 96, Bruker Daltonics, Germany). Microdroplets (6 µl) containing bacterial suspension and antibiotic or antibiotic/inhibitor in cation-adjusted Mueller-Hinton broth were spotted on the target and incubated for 4 hours at 36°C in a humidity chamber to avoid evaporation. The medium was subsequently removed and MALDI-TOF MS of the cells adhered to the target's surface was performed. The minimum inhibitory concentration (MIC) was considered to be the lowest concentration at which the MALDI Biotyper software yielded no organism identification. Synergy was defined by an eightfold or greater reduction of the meropenem MIC in the presence of an inhibitor. The absence of synergy between meropenem and inhibitors as well as high-level temocillin resistance was considered suggestive of OXA production. Results were processed and interpreted with a computer-based algorithm.
Results. After 4 hours, the method was able to correctly detect the foreknown resistance mechanisms of all tested strains (KPC, MBL, OXA, and AmpC), yielding results that agreed with those obtained by performing broth microdilution with 18 hours of incubation.
Conclusion. The DOT-MGA approach allowed easy identification and differentiation of carbapenemase production, delivering reliable results one day earlier than the usual phenotypic methods, thus displaying great potential for the clinical setting.
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